Peptides impairing pbx dependent gene regulation
AssigneeSt. George's Hospital Medical School
InventorsRichard George Morgan, Ruth Pettengell, Nicolas Pierre Forraz, Colin McGuckin
Life of this patent
Estimating the term…
Loading patent…
AssigneeSt. George's Hospital Medical School
InventorsRichard George Morgan, Ruth Pettengell, Nicolas Pierre Forraz, Colin McGuckin
Estimating the term…
The present invention relates to peptides which impair PBX-dependent regulation of gene transcription. In particular, the invention provides the use of a peptide comprising the amino acid sequence X1 X2 X3 W M X4 X5 X6 X7, wherein the sequence X1 to X7 is an amino acid sequence comprising at least 9 amino acids, which may optionally be interrupted by one or two amino acid residues between one or more of the 9 amino acid positions defined herein; X1 is selected from W, T, PE, KQI, VV, PQT, H, RI and absent; X2 is an amino acid with an aromatic side chain; X3 is P or D; X4 is an amino acid with a basic side chain; X5 is an amino acid with a charged side chain; X6 is an amino acid with a charged side chain; and X7 is an amino acid with a basic side chain or Serine; in the manufacture of a medicament for treating or preventing a disorder in which aberrant cell division occurs.
A method of treating a disorder in which aberrant cell division occurs in a human or animal comprising administering to said human or animal a therapeutically effective amount of a peptide comprising the amino acid sequence
The method according to claim wherein said disorder is a cancer.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.